Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Francesco Ravera und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Medical Specialties, University of Genoa, Genova, Italy. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, COVID-19 Vaccines, Rituximab, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, University of Genoa, Associazione Italiana Contro le Leucemie - Linfomi e Mieloma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Medical Specialties, University of Genoa, Genova, Italy.
- IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Sidra Medicine, Doha, Qatar.
- Department of Experimental Medicine, University of Genoa, Genova, Italy.
- Department of Internal Medicine and Medical Specialties, University of Genoa, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Sidra Medicine, Doha, Qatar; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
Förderung
- Italian Association for Cancer Research
- University of Genoa
- Associazione Italiana Contro le Leucemie - Linfomi e Mieloma
- Ministry of Health
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Alleanza Contro il Cancro
Zitieren
APA
Ravera, F., Dameri, M., Lombardo, I., Stabile, M., Becherini, P., Fallani, N., Scarsi, C., Cigolini, B., Gentilcore, G., Domnich, A., Zullo, L., Cella, E., Francia, G., Montanari, E., Orsi, A., Bellodi, A., Ferrando, F., Rinchai, D., Ballerini, F., …, & Zoppoli, G. (2025). Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115838
Vancouver
Ravera F, Dameri M, Lombardo I, Stabile M, Becherini P, Fallani N, et al. Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115838
BibTeX
@article{Ravera2025,
author = {Ravera, Francesco and Dameri, Martina and Lombardo, Isabella and Stabile, Mario and Becherini, Pamela and Fallani, Neri and Scarsi, Camilla and Cigolini, Benedetta and Gentilcore, Giusy and Domnich, Alexander and Zullo, Lodovica and Cella, Eugenia and Francia, Giulia and Montanari, Eugenia and Orsi, Andrea and Bellodi, Andrea and Ferrando, Fabio and Rinchai, Darawan and Ballerini, Filippo and Bruzzone, Bianca and Chaussabel, Damien and Grivel, Jean-Charles and Genova, Carlo and Lemoli, Roberto Massimo and Bedognetti, Davide and Ballestrero, Alberto and Ferrando, Lorenzo and Zoppoli, Gabriele},
title = {Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115838}
}
EUVIMED